Magstim Group Appoints Luciën van Os as Chief Technology Officer for Global Minimally-Invasive Neurotechnology Portfolio


Van Os To Oversee Product & Technology Development For Magstim TMS, Electrical Geodesics (EGI) EEG, Technomed Neurophysiology and Neurosign Intraoperative Nerve Monitoring Brands

Van Os To Oversee Product & Technology Development For Magstim TMS, Electrical Geodesics (EGI) EEG, Technomed Neurophysiology and Neurosign Intraoperative Nerve Monitoring Brands

MINNEAPOLIS, Minn. – Magstim Group, a global non-invasive and minimally invasive neurotechnology leader, today announces the appointment of Luciën van Os as Chief Technology Officer to lead product and technology development for Magstim TMS, Electrical Geodesics (EGI), Technomed and Neurosign brands. Van Os will lead product technology and manage the Group’s patent portfolio and research collaborations.

“Luciën is globally recognized for his medical device technology leadership at Medtronic, Gambro/Baxter, Sphere Medical, TMSi, Philips, and Ericsson,” said Lothar Krinke, PhD, Group CEO, Magstim Group. “Luciën’s deep experience will accelerate our growth and innovation in neurotechnology markets. Our mission is to develop the best non-invasive and minimally-invasive technologies for researchers and clinicians.”

On July 1, Magstim Group acquired the product portfolio of Electrical Geodesics, Inc. (EGI) from Royal Philips. Van Os will oversee this High-Density EEG technology division and ongoing collaborations for Magstim Group brands. An engineer by education, van Os brings the Magstim Group years of experience growing technology businesses and building cross-cultural and cross-border collaborations. Based at the Group’s Netherlands office, van Os will work globally.

These are some of the world’s most trusted neurotechnology brands, now under one umbrella organization,” said Van Os. “I am so excited to lead this technology and collaborate with our network of researchers and scientists. More than ever, their work is changing the course of healthcare and science, and I am honored to bring my strategic and technical leadership experience.”  

Magstim and EGI both have a 30+ year history working with clinicians and researchers to advance treatments for mental health and brain disorders and collaborate to advance the field of neuroscience. Innovations from Neurosign are used for interoperative nerve monitoring to help preserve nerves during surgical procedures. Technomed designs and manufactures neurophysiology accessories used for EMG and EEG studies.

Magstim Group Brands Unite As Welcony

According to Krinke, all Magstim Group brands are now united under a new umbrella organization named Welcony. Magstim TMS, EGI, Technomed and Neurosign will continue as independent brands. Operating as Welcony enables integrated brand growth and service through shared resources for research & development, manufacturing and leadership.

About Welcony

Globally, Welcony technologies have supported thousands of research labs, clinics, hospitals and universities that focus on mental health, brain disorders, cognitive neuroscience and neuromonitoring. Key brands include Magstim Transcranial Magnetic Stimulation (TMS), Electrical Geodesics Inc. (EGI) high-density EEG, Technomed Clinical Neurophysiology and Neurosign Nerve Safety Monitoring. Welcony is backed by Telegraph Hill Partners, a San Francisco based private equity company.

#  #  #  #

Media Contact: Mark Sejvar,, 323-363-3530


Product Enquiry

Fill in your details
and we’ll be in touch